Contralateral metachronous pulmonary carcinoid tumor 7 years after lobectomy

Area of Science:

• Oncology
• Pulmonary Medicine
• Neuroendocrine Tumors

Background:

• Carcinoid tumors arise from neuroendocrine cells, commonly affecting the lungs and gastrointestinal tract.
• Surgical resection is the standard treatment for localized carcinoid tumors.
• Long-term recurrence and metachronous tumor development pose significant clinical challenges.

Observation:

• A 77-year-old male patient underwent lobectomy for a pulmonary carcinoid tumor.
• Seven years post-surgery, the patient developed a contralateral recurrence of the carcinoid tumor.
• This case illustrates a rare instance of metachronous tumor development.

Findings:

• Pulmonary carcinoid tumors have a potential for late recurrence, even after successful initial resection.
• Contralateral recurrence can occur years after primary treatment, underscoring tumor biology.
• Metachronous tumor development necessitates vigilant follow-up protocols.

Implications:

• Emphasizes the critical need for robust, long-term surveillance strategies in patients treated for pulmonary carcinoid tumors.
• Highlights the importance of considering neuroendocrine tumor recurrence risk in long-term patient management.
• Suggests that extended follow-up may be warranted to improve outcomes for carcinoid tumor survivors.